Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
February 08, 2024
With several replenishment campaigns set for 2024-2025, a fundraising pileup is on the horizon. Close to a dozen major development funds—including the World Bank’s International Development Association (IDA), thematic funds like Gavi, and new entities like the Loss and Damage Fund—could aim to raise...
POLICY PAPERS
July 26, 2023
Public and policy discourse has been imprecise in its definition of what constitutes a global public good, with implications for our understanding of how MDBs contribute to them. Once this is corrected for, it becomes apparent that, except under restrictive conditions that are unlikely to hold in th...
Blog Post
July 26, 2023
The effects of anthropogenic climate change are upon us, and the time for serious action is past due. In this context it is unsurprising that many observers are turning to the multilateral development banks (MDBs) for this action. These are institutions whose names inspire the potential for grand ac...
Blog Post
June 05, 2023
Recent CGD events have shown several bright spots for the evidence-informed policy agenda, demonstrating leadership commitment to evidence generation and use. The new World Bank president, Ajay Banga, called for the institution to deepen its role as a knowledge bank in a recent speech at CGD. Newly ...
CGD NOTES
June 05, 2023
The World Bank’s lending function is important and irreplaceable. But providing countries with an important source of financing and investing in evidence do not have to be in tension. The role of evaluation should shift from an assessment function to one in which evaluation is a central tool of pro...
CGD NOTES
March 20, 2023
With global challenges high on the international agenda and financing set to increase in the coming years, a big push on evidence, backed by dedicated resources, is essential. This note makes the case for a reinvigorated evidence agenda to boost the impact of financing for development and global pub...
CGD NOTES
December 14, 2022
Almost a year after two oral antiviral treatments received emergency use authorization, demand is extremely low. In this note, we argue that governments and their donor partners should use data and evidence to consider the economic and clinical rationale for registering, financing, purchasing, and d...